Patients with advanced melanoma experienced high response rates when treated with commercial Amtagvi in a real-world clinical ...

The U.S. Food and Drug Administration (FDA) has approved an update to the prescribing information for Yescarta (axicabtagene ...

Distinct UV mutational signatures in cutaneous DNA reinforce UV radiation as the predominant environmental carcinogen underlying most skin cancers. Genetic counseling is best targeted to strong ...

Mantras are portrayed as intentional phrases used to align consciousness and cognition toward well-being, clarity, and self-directed goals amid cancer-related stressors. Early mantra work emphasizes ...

FDA orphan designation for zenocutuzumab‑zbco targets NRG1 fusion–positive advanced cholangiocarcinoma, a small molecular subset within an aggressive malignancy with <15% five-year survival. Orphan ...

Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of medicine ...

FDA labeling now recommends DPYD variant testing before initiating capecitabine or 5-FU, except when immediate treatment is ...

Treatment with relacorilant plus Abraxane (nab-paclitaxel) may offer a broader option for patients with platinum-resistant ...

Ongoing monitoring remains a cornerstone of survivorship care for patients with cancer, helping detect recurrence early and ...

A combination immunotherapy approach using Ampligen (rintatolimod) and Imfinzi (durvalumab) showed clinical activity for ...

Nocturnal symptoms and musculoskeletal pain are filtered through relapse fear, driving repetitive interpretation of ...

Sabari recommends regular activity, such as walking 30 minutes a day several times a week, to help maintain lung strength.